Clinical Trial

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 31, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
Directly examine whether early (6-month) imaging with DaTscan and \[¹⁸F\] AV-133 will provide an early signal of disease progression in recently diagnosed untreated PD patients.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-08-06; most recent amendment 2024-10-30.
Status change: Recruiting → Active, Not Recruiting 2023-10-18
Status change: Not Yet Recruiting → Recruiting 2020-09-15
Trial Details
NCT Number NCT04507139
Lead Sponsor Michael J. Fox Foundation for Parkinson's Research
Conditions Parkinson Disease
Enrollment 50 participants
Start Date 2020-09-10
Primary Completion 2025-06 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2024-10-31